SCHEMBL23929995

SCHEMBL23929995

C=Cc1cnc2c(OC)cc(C(=O)OC)cc2c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGDS O60760 1/20 0.42
KDM4E B2RXH2 5/20 0.42
ALDH1A1 P00352 3/20 0.42
PARP1 P09874 1/20 0.41
CYP3A4 P08684 2/20 0.40
PSMD14 O00487 1/20 0.40
MAPT P10636 4/20 0.38
KMT2A Q03164 4/20 0.38
MEN1 O00255 2/20 0.38
PTPN11 Q06124 1/20 0.38
LMNA P02545 1/20 0.38
ATM Q13315 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
TSHR P16473 1/20 0.38
CNR2 P34972 1/20 0.36
GLA P06280 1/20 0.36
HPGD P15428 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
ALOX5 P09917 1/20 0.36
NFKB1 P19838 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23930160 0.88 PSMD14 (0.44) HPGDSKDM4EALDH1A1CYP3A4PSMD14
SCHEMBL23883070 0.81 KDM4E (0.46) HPGDSKDM4EALDH1A1CYP3A4PSMD14
SCHEMBL23905404 0.81 ATM (0.47) HPGDSKDM4EALDH1A1PARP1CYP3A4
SCHEMBL23904892 0.81 KDM4E (0.46) HPGDSKDM4EALDH1A1CYP3A4PSMD14
SCHEMBL23905372 0.80 KDM4E (0.45) HPGDSKDM4EALDH1A1CYP3A4PSMD14
SCHEMBL23883090 0.80 ALDH1A1 (0.45) HPGDSKDM4EALDH1A1CYP3A4PSMD14
SCHEMBL23166783 0.80 KDM4E (0.45) HPGDSKDM4EALDH1A1CYP3A4PSMD14
SCHEMBL23905883 0.77 HSD17B2 (0.46) HPGDSKDM4EALDH1A1MAPTKMT2A
SCHEMBL23958665 0.76 CYP3A4 (0.43) HPGDSKDM4EALDH1A1CYP3A4PSMD14
SCHEMBL23905505 0.76 NOTUM (0.46) HPGDSKDM4EALDH1A1CYP3A4PSMD14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230203004-A1 RSV INHIBITING 3-SUBSTITUTED QUINOLINE AND CINNOLINE DERIVATIVES JANSSEN PHARMACEUTICA NV (BE) 2023-06-29 US disclosed
US-20230203004-A1 RSV INHIBITING 3-SUBSTITUTED QUINOLINE AND CINNOLINE DERIVATIVES JANSSEN PHARMACEUTICA NV (BE) 2023-06-29 US disclosed
US-20230203004-A1 RSV INHIBITING 3-SUBSTITUTED QUINOLINE AND CINNOLINE DERIVATIVES JANSSEN PHARMACEUTICA NV (BE) 2023-06-29 US disclosed
EP-4139293-A1 RSV INHIBITING 3-SUBSTITUTED QUINOLINE AND CINNOLINE DERIVATIVES Janssen Sciences Ireland Unlimited Company (IE) 2023-03-01 EP disclosed
CN-115461336-A RSV inhibiting 3-substituted quinoline and cinnoline derivatives 爱尔兰詹森科学公司 2022-12-09 CN disclosed
WO-2021214136-A1 RSV INHIBITING 3-SUBSTITUTED QUINOLINE AND CINNOLINE DERIVATIVES Janssen Sciences Ireland Unlimited Company (IE) 2021-10-28 WO disclosed
WO-2021214136-A1 RSV INHIBITING 3-SUBSTITUTED QUINOLINE AND CINNOLINE DERIVATIVES Janssen Sciences Ireland Unlimited Company (IE) 2021-10-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230203004-A1 RSV INHIBITING 3-SUBSTITUTED QUINOLINE AND CINNOLINE DERIVATIVES ACE2, SIRT7, ACE HPGDS 4259/4885KDM4E 3733/4885ALDH1A1 1630/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.